EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation

Tong Lu, Hongtao Song, Limin He, Zhihao Hu, Yu Li, Chao Xu, Shaojie Liu, Jun Jiang, Yike Zhou, Zhengxuan Li, Zeyu Li, Keying Zhang und 7 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202507943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Tong Lu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. Hauptthemen laut MEDLINE: Kidney Transplantation, T-Lymphocytes, Regulatory, Graft Rejection, Immune Tolerance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Capability Support Program of Shaanxi, Innovation Capability Enhancement Program of Shaanxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplantation remains the optimal treatment for end‐stage renal disease, yet faces persistent challenges including organ shortages and risk of infection due to systemic immunosuppression. Cell therapy is expected to replace immunosuppressive agents. However, while Treg cell therapy can mitigate immune rejection, it fails to significantly prolong graft survival because peripherally induced Treg cells exhibit transdifferentiation potential in the circulatory system. Recent advances in nanocarrier systems offer promising approaches for achieving graft‐specific immune tolerance. Through single‐cell sequencing analysis, CD248 is identified as a pivotal stromal cell marker in renal allograft rejection, modulated by HIF‐1α and IL‐1β signaling pathways. Leveraging macrophage membrane coating technology, nanoparticles co‐loaded is developed with IL‐2 and TGF‐β expressing plasmids. These nanoparticles incorporate a CD248‐targeting antibody (IgG78) and plasmids containing a kidney‐specific NPHS2 promoter, enabling dual‐targeting capability for localized gene expression. In vitro validation demonstrated efficient differentiation of CD4⁺T cells into functional Treg populations. In rat renal transplantation models, nanoparticle treatment increased Treg cells in the graft and significantly prolonged allograft survival, improved renal function, and attenuated complement deposition. The findings establish a targeted nanoparticle platform that promotes graft‐specific immune tolerance through localized Treg cell expansion, potentially reducing dependence on systemic immunosuppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationT-Lymphocytes, RegulatoryGraft RejectionImmune ToleranceAnimalsRatsGraft SurvivalNanoparticlesMale

Stichwörter der Autor:innen

CD248/endosialin/tem‐1immune tolerancekidney transplantationnanoparticlesregulatory t cells

Autor:innen und Institutionen

  • Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
  • Department of Urology, The 900th Hospital of Joint Logistic Support Force, PLA (Fuzong Clinical Medical College of Fujian Medical University), Fuzhou, 350025, China.
  • Department of Urology, Daping Hospital, Army Medical University, Chongqing, 400042, China.
  • Department of Urology, The Air Force Hospital of Eastern Theater Command, Nanjing, 210001, China.
  • Division of Cancer Biology, Laboratory Animal Center, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
  • Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, China.

ORCID-Profile: Weijun Qin

Förderung

  • National Natural Science Foundation of China
  • Innovation Capability Support Program of Shaanxi
  • Innovation Capability Enhancement Program of Shaanxi
  • First Affiliated Hospital of Fourth Military Medical University Aviation Clinical Medicine Special Research Project

Zitieren

APA

Lu, T., Song, H., He, L., Hu, Z., Li, Y., Xu, C., Liu, S., Jiang, J., Zhou, Y., Li, Z., Li, Z., Zhang, K., Ma, S., Qi, R., Han, S., Shi, C., Wen, W., Han, D., & Qin, W. (2026). Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation. Advanced Science. https://doi.org/10.1002/advs.202507943

Vancouver

Lu T, Song H, He L, Hu Z, Li Y, Xu C, et al. Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation. Advanced Science. 2026. doi:10.1002/advs.202507943

BibTeX
@article{Lu2026,
  author = {Lu, Tong and Song, Hongtao and He, Limin and Hu, Zhihao and Li, Yu and Xu, Chao and Liu, Shaojie and Jiang, Jun and Zhou, Yike and Li, Zhengxuan and Li, Zeyu and Zhang, Keying and Ma, Shuaijun and Qi, Ruochen and Han, Shichao and Shi, Changhong and Wen, Weihong and Han, Donghui and Qin, Weijun},
  title = {Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202507943}
}
Kostenlos starten →